A Look at Iterum Therapeutics's Upcoming Earnings Report
A Look at Iterum Therapeutics's Upcoming Earnings Report
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).Iterum Therapeutics (NASDAQ:ITRM) is set to give its latest quarterly earnings report on Thursday, 2024-11-14. Here's what investors need to know before the announcement.
iterum therapeutics（纳斯达克: ITRM）定于2024年11月14日星期四发布最新的季度财报。投资者在公布之前需要了解的内容如下。
Analysts estimate that Iterum Therapeutics will report an earnings per share (EPS) of $-0.20.
分析师估计iterum therapeutics的每股收益（EPS）为-0.20美元。
Iterum Therapeutics bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
iterum therapeutics的看涨者将希望听到该公司宣布他们不仅击败了那一预期，而且还提供了积极的指引，或者预测未来季度的增长。
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
新投资者应该注意，有时不是盈利与否影响股票价格最大，而是其提供的指导或预测。
Past Earnings Performance
过去的盈利表现
During the last quarter, the company reported an EPS beat by $0.22, leading to a 0.83% increase in the share price on the subsequent day.
在上个季度，该公司报告的每股收益优于0.22美元，导致股价在随后的一天上涨了0.83%。
Here's a look at Iterum Therapeutics's past performance and the resulting price change:
这里是iterum therapeutics以往的表现和随之而来的价格变动：
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.45 | -0.72 | -0.93 | -0.91 |
| EPS Actual | -0.23 | -0.38 | -0.81 | -1.20 |
| Price Change % | 1.0% | -1.0% | -3.0% | 11.0% |
| 季度 | 2024年第二季度 | 2024年第一季度 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| 每股收益预估值 | -0.45 | -0.72 | -0.93 | -0.91 |
| 每股收益实际值 | -0.23 | -0.38 | -0.81 | -1.20 |
| 价格变更% | 1.0% | -1.0% | -3.0% | 11.0% |
Performance of Iterum Therapeutics Shares
iterum therapeutics股价表现
Shares of Iterum Therapeutics were trading at $1.48 as of November 12. Over the last 52-week period, shares are up 30.43%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
截至11月12日，iterum therapeutics的股价为1.48美元。在过去的52周里，股价上涨了30.43%。考虑到这些回报通常是正面的，长期股东在参与这次财报发布时应该感到满意。
To track all earnings releases for Iterum Therapeutics visit their earnings calendar on our site.
要追踪iterum therapeutics的所有财报发布，请访问我们网站上的财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文是由Benzinga的自动内容引擎生成，并由编辑审核。
